BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 31036064)

  • 1. Dual prognostic role of 2-oxoglutarate-dependent oxygenases in ten cancer types: implications for cell cycle regulation and cell adhesion maintenance.
    Chang WH; Forde D; Lai AG
    Cancer Commun (Lond); 2019 Apr; 39(1):23. PubMed ID: 31036064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional landscape of DNA repair genes underpins a pan-cancer prognostic signature associated with cell cycle dysregulation and tumor hypoxia.
    Chang WH; Lai AG
    DNA Repair (Amst); 2019 Jun; 78():142-153. PubMed ID: 31054516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel signature derived from immunoregulatory and hypoxia genes predicts prognosis in liver and five other cancers.
    Chang WH; Forde D; Lai AG
    J Transl Med; 2019 Jan; 17(1):14. PubMed ID: 30626396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The panoramic picture of pepsinogen gene family with pan-cancer.
    Shen S; Li H; Liu J; Sun L; Yuan Y
    Cancer Med; 2020 Dec; 9(23):9064-9080. PubMed ID: 33067881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust prognostic gene expression signatures in bladder cancer and lung adenocarcinoma depend on cell cycle related genes.
    Dancik GM; Theodorescu D
    PLoS One; 2014; 9(1):e85249. PubMed ID: 24465512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing Pan-cancer Gene Expression Survial Analysis by Inclusion of Non-coding RNA.
    Ye B; Shi J; Kang H; Oyebamiji O; Hill D; Yu H; Ness S; Ye F; Ping J; He J; Edwards J; Zhao YY; Guo Y
    RNA Biol; 2020 Nov; 17(11):1666-1673. PubMed ID: 31607216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic pan-cancer analyses of the potential function of the Golgi scaffold protein PAQR3.
    Ling ZN; Hong LL; Wu J; Ling ZQ
    Sci Rep; 2024 Feb; 14(1):3030. PubMed ID: 38321173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
    Tawk B; Schwager C; Deffaa O; Dyckhoff G; Warta R; Linge A; Krause M; Weichert W; Baumann M; Herold-Mende C; Debus J; Abdollahi A
    Radiother Oncol; 2016 Feb; 118(2):350-8. PubMed ID: 26711490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-cancer genomic amplifications underlie a WNT hyperactivation phenotype associated with stem cell-like features leading to poor prognosis.
    Chang WH; Lai AG
    Transl Res; 2019 Jun; 208():47-62. PubMed ID: 31028732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Violations of proportional hazard assumption in Cox regression model of transcriptomic data in TCGA pan-cancer cohorts.
    Zeng Z; Gao Y; Li J; Zhang G; Sun S; Wu Q; Gong Y; Xie C
    Comput Struct Biotechnol J; 2022; 20():496-507. PubMed ID: 35070171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PreMSIm: An R package for predicting microsatellite instability from the expression profiling of a gene panel in cancer.
    Li L; Feng Q; Wang X
    Comput Struct Biotechnol J; 2020; 18():668-675. PubMed ID: 32257050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-Cancer Multiomics Analysis of TC2N Gene Suggests its Important Role(s) in Tumourigenesis of Many Cancers.
    Qureshi MA; Khan S; Tauheed MS; Syed SA; Ujjan ID; Lail A; Sharafat S
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3199-3209. PubMed ID: 33247676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model.
    de Velasco G; Culhane AC; Fay AP; Hakimi AA; Voss MH; Tannir NM; Tamboli P; Appleman LJ; Bellmunt J; Kimryn Rathmell W; Albiges L; Hsieh JJ; Heng DY; Signoretti S; Choueiri TK
    Oncologist; 2017 Mar; 22(3):286-292. PubMed ID: 28220024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrative pan-cancer investigation reveals common genetic and transcriptional alterations of AMPK pathway genes as important predictors of clinical outcomes across major cancer types.
    Chang WH; Lai AG
    BMC Cancer; 2020 Aug; 20(1):773. PubMed ID: 32807122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A pan-cancer analysis of TTC9A expression level and its correlation with prognosis and immune microenvironment].
    Yao Y; Liu J; Zhou X; Liu Z; Qiu S; He Y; Zhou X
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jan; 44(1):70-82. PubMed ID: 38293978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative omics analysis reveals relationships of genes with synthetic lethal interactions through a pan-cancer analysis.
    Guo L; Li S; Qian B; Wang Y; Duan R; Jiang W; Kang Y; Dou Y; Yang G; Shen L; Wang J; Liang T
    Comput Struct Biotechnol J; 2020; 18():3243-3254. PubMed ID: 33240468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
    Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
    Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic cancer survival analysis defines a signature that predicts outcome.
    Raman P; Maddipati R; Lim KH; Tozeren A
    PLoS One; 2018; 13(8):e0201751. PubMed ID: 30092011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling protein signature predicts clinical outcome of non-small-cell lung cancer.
    Jin BF; Yang F; Ying XM; Gong L; Hu SF; Zhao Q; Liao YD; Chen KZ; Li T; Tai YH; Cao Y; Li X; Huang Y; Zhan XY; Qin XH; Wu J; Chen S; Guo SS; Zhang YC; Chen J; Shen DH; Sun KK; Chen L; Li WH; Li AL; Wang N; Xia Q; Wang J; Zhou T
    BMC Cancer; 2018 Mar; 18(1):259. PubMed ID: 29510676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular profiling of multiple human cancers defines an inflammatory cancer-associated molecular pattern and uncovers KPNA2 as a uniform poor prognostic cancer marker.
    Rachidi SM; Qin T; Sun S; Zheng WJ; Li Z
    PLoS One; 2013; 8(3):e57911. PubMed ID: 23536776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.